ACTRN12607000314426已完成3 期
A Randomised, controlled trial of mask use in control of respiratory virus transmission in Health Care Workers
The Children's Hospital at Westmead0 个研究点目标入组 1,441 人开始时间: 2007年6月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,441
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Must not have had any influenza like illness within a week prior to recruitment. Must sign the consent form.
排除标准
- •Beard or facial hair
研究者
相似试验
已完成
不适用
The Bushfire, Respiratory protection, Emphysema, bronchitis and Asthma Triggering Health Effects (BREATHE) study – evaluating the effectiveness of mask and respirator usage against respiratory symptoms in Australian adults with asthma or chronic obstructive pulmonary disease during bushfire seasoRespiratory illnessBush fire smoke exposureRespiratory - AsthmaRespiratory - Chronic obstructive pulmonary diseaseRespiratory - Other respiratory disorders / diseasesBronchiectasisAsthmaChronic bronchitisEmphysemaACTRN12620000801910niversity of New South Wales247
已完成
不适用
The MONT (Mask Or Nasal Tube) Trial: A randomised controlled trial of mask versus nasal tube for the stabilisation of preterm infants (born between 24 and 29 complete weeks gestation) in the delivery room.bronchopulmonary dysplasianeonatal resuscitationReproductive Health and Childbirth - Childbirth and postnatal careneonatal respiratory distress syndromeACTRN12610000230055Royal Women's Hospital648
已完成
不适用
A cluster-randomised study of mask use in control of influenza or other respiratory virus transmission within the family with at least two adults and only one ill childACTRN12607000183482ational Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases100
进行中（未招募）
不适用
A placebo controlled trial investigating the safety and effectiveness of AZD4017 in patients with raised intra-ocular pressureRaised Intra-Ocular Pressure or primaryopen angle glaucoma (POAG) on anti-glaucoma monotherapy that has been stable indose for at least 30 days prior to screening.MedDRA version: 14.1Level: LLTClassification code 10036719Term: Primary open angle glaucomaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10022809Term: Intraocular pressure raisedSystem Organ Class: 10022891 - InvestigationsEUCTR2010-020932-20-SEAstraZeneca AB60
进行中（未招募）
1 期
A placebo controlled trial investigating the safety and effectiveness of AZD4017 in patients with raised intra-ocular pressureEUCTR2010-020932-20-GBAstraZeneca AB60